Finland Blood And Blood Forming Organs Medicine Sales is set to reach $348 Million by 2026 from $301.1 Million, is expected to increase 6.8% per year. Since 2017, the market rose 6.1% year on year totalising $27,250 Million. Germany, Italy and South Korea respectively were numbers 2, 3 and 4 in this ranking.
How does Finland perform in Blood Disease?
Forecast: Blood and Blood Forming Organs Medicine Sales in Finland
- US Dollars PPP Per Capita
- 2024 to 2028
- ReportLinker Research
Forecast: Blood and Blood Forming Organs Medicine Sales in Finland
- US Dollars Per Capita
- 2024 to 2028
- ReportLinker Research
Forecast: Blood and Blood Forming Organs Medicine Sales in Finland
- Percent of Total Sales
- 2024 to 2028
- ReportLinker Research
Forecast: Blood and Blood Forming Organs Medicine Sales in Finland
- Million Euros
- 2024 to 2028
- ReportLinker Research
Forecast: Blood and Blood Forming Organs Medicine Sales in Finland
- Million US Dollars PPP
- 2024 to 2028
- ReportLinker Research
Forecast: Infant Mortality Rate Due to Haemorrhagic and Haematological Disorders of Fetus and Newborn, by Sex in Finland
- Units (Deaths) Per Thousand Live Births
- 2024 to 2028
- ReportLinker Research
Forecast: Prevalence of Anemia in Finland
- Percent of Children Under 5
- 2024 to 2028
- ReportLinker Research
Forecast: In-Patient Average Length of Stay for Anaemias, by Sex and Age in Finland
- Days
- 2024 to 2028
- ReportLinker Research